Nature

Redefining in vitro drug testing

UK-based DefiniGEN has developed iPSC-derived cell lines that can replace primary human hepatocytes for toxicity testing and accelerate the development of novel liver-targeted therapeutics. Drugmakers ...
Regulatory Affairs Professionals Society

FDA finalizes two guidances for industry on establishing bioequivalence

The US Food and Drug Administration (FDA) finalized two guidances on studies on 28 May to assist sponsors in establishing bioequivalence (BE) for new and generic drugs. One focuses on BE studies with ...
GEN

Replacing Animals in Regulatory Testing and Scientific Research: Where Are We?

Recent years have seen a growing movement away from animal testing and toward models that more closely replicate human physiology. This shift aims to protect animal welfare while concurrently ...
IFLScience

In Vivo Vs In Vitro: What Do They Actually Mean?

Etelka is a post-doctoral research fellow exploring aerosol science with biology and engineering.View full profile Etelka is a post-doctoral research fellow exploring aerosol science with biology and ...
Healio

FDA efforts to reduce animal testing signal shift toward AI, organ-on-chip study methods

Please provide your email address to receive an email when new articles are posted on . The FDA announced plans in 2025 to reduce animal testing requirements in biomedical research. New approach ...